Can a simple bedside test save sepsis patients from worsening?

NCT ID NCT06910891

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether measuring tiny blood flow (microcirculation) in sepsis patients in the emergency room can help doctors start fluid treatment earlier. Researchers will compare standard care plus these measurements to standard care alone in 556 adults with suspected sepsis. The goal is to see if this extra monitoring reduces the number of patients who get worse or need intensive care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
measurement of peripheral perfusion index and marbling assessment
What this could lead to
If it works, this could help doctors detect hidden blood flow problems in sepsis patients earlier, potentially reducing complications and ICU admissions.
What could go wrong
This is an early-stage study focused on a diagnostic test, not a treatment. The test may not improve outcomes, and results may not apply to all sepsis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMERGENCY CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brive Hospital

    RECRUITING

    Brivé, 19100, France

  • Guéret Hospital

    RECRUITING

    Guéret, 23000, France

  • Limoges University Hospital

    RECRUITING

    Limoges, 87000, France

  • Saint Junien Hospital

    RECRUITING

    Saint-Junien, 87200, France

  • Tulle Hospital

    RECRUITING

    Tulle, 19012, France

  • Ussel Hospital

    RECRUITING

    Ussel, 19200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.